Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 29 of 31

COMPLETED NA

Vitamin D, Insulin Resistance, and Cardiovascular Disease

NCT00736632

TERMINATED Phase 2

A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis

NCT00352755

COMPLETED Phase 1

Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients

NCT00334321

COMPLETED

Effects of Antipsychotic Medications on Energy Intake and Expenditure

NCT00836251

COMPLETED Phase 1

The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients

NCT00316472

COMPLETED NA

Fat Metabolism in Response to Acute Diet- and Exercise-induced Changes in Energy Balance

NCT00830999

COMPLETED NA

Clinical Study of Cochlear Implants in Adults With Asymmetrical Hearing Loss

NCT02004535

COMPLETED Phase 4

Metabolic Effects of Antipsychotics in Children

NCT00205699

COMPLETED NA

Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)

NCT00455403

TERMINATED Phase 2

A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer

NCT00352690

COMPLETED

Deep Brain Stimulation of the Subthalamic Nucleus (STN) and Cognitive Control

NCT00917722

COMPLETED NA

Effect of Aromatase Inhibitors on Bones and Genes

NCT00603967

COMPLETED NA

Addition of Phytosterols to a Low Phytosterol Diet

NCT00860054

TERMINATED Phase 2

PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer

NCT00263198

COMPLETED Phase 1

Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer

NCT00325598

COMPLETED Phase 1

Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients

NCT00359866

COMPLETED Phase 1

Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)

NCT00634556

COMPLETED Phase 4

Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)

NCT00548132

TERMINATED Phase 2

A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients

NCT00263211

TERMINATED Phase 2

Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma

NCT02469116

TERMINATED

Evaluating Quality of Life for Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation

NCT00675376

TERMINATED NA

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

NCT00235781

COMPLETED Phase 2

A Comparison of Casting and Splinting in Pediatric Radial Buckle Fractures

NCT01010347

COMPLETED NA

A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients

NCT00355316

COMPLETED Phase 4

Yoga for the Management of HIV-Metabolic Syndromes

NCT00627380

COMPLETED Early Phase 1

High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status

NCT00263185

COMPLETED Early Phase 1

Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation

NCT00314743

COMPLETED NA

Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling

NCT00603720

TERMINATED Phase 2

PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

NCT00240162

TERMINATED

Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients

NCT00301379

COMPLETED NA

Quantification of Intramyocardial Lipid by Proton Magnetic Resonance Spectroscopy

NCT00469911

COMPLETED Phase 2

Study Evaluating Ways of Preventing Patients From Being Awake During High-Risk Surgery and Anesthesia

NCT00281489

COMPLETED

The Natural History of Asymptomatic Rotator Cuff Tears

NCT00923858

COMPLETED

Effect of Gastric Bypass-induced Weight Loss on Myocardial Structure, Function and Metabolism

NCT00841009

COMPLETED Phase 2

Use of Thalidomide in Patients With Arachnoiditis

NCT00284505

COMPLETED Early Phase 1

Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

NCT00802815

COMPLETED Phase 1

Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors

NCT00660426

COMPLETED NA

Botulinum Toxin Effects on Plantar Ulcer Recurrence

NCT00845897

TERMINATED Phase 2

A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma

NCT00241371

COMPLETED NA

Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma

NCT00590941

COMPLETED Phase 4

Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole

NCT00205660

COMPLETED NA

Worksite Phone Counseling for Smoking Cessation

NCT02730260

COMPLETED Phase 3

Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors

NCT00116857

COMPLETED NA

Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus

NCT00133107

COMPLETED Phase 3

Weight Loss and Exercise in Obese, Physically Limited, Older Women and Men

NCT00146107

COMPLETED NA

Determining Metabolic Effects of Valproate and Antipsychotic Therapy

NCT00167934

COMPLETED Phase 3

Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial

NCT00072761

COMPLETED Phase 3

Exercise and Testosterone Therapy in Elderly Men With Physical Frailty

NCT00345969

COMPLETED NA

Obesity and Nonalcoholic Fatty Liver Disease

NCT00262964

COMPLETED

Development of a Face Valid Executive Functioning Task

NCT00918112

← Previous Page 29 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.